These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 31216540

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
    Goldberg A, Yogev A, Confino-Cohen R.
    Int Arch Allergy Immunol; 2011; 156(1):90-8. PubMed ID: 21447964
    [Abstract] [Full Text] [Related]

  • 3. Safety of Ultrarush Venom Immunotherapy: Comparison Between Children and Adults.
    Nittner-Marszalska M, Cichocka-Jarosz E, Małaczyńska T, Kraluk B, Rosiek-Biegus M, Kosinska M, Pawłowicz R, Lis G.
    J Investig Allergol Clin Immunol; 2016; 26(1):40-7. PubMed ID: 27012015
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Venom immunotherapy for preventing allergic reactions to insect stings.
    Boyle RJ, Elremeli M, Hockenhull J, Cherry MG, Bulsara MK, Daniels M, Oude Elberink JN.
    Cochrane Database Syst Rev; 2012 Oct 17; 10(10):CD008838. PubMed ID: 23076950
    [Abstract] [Full Text] [Related]

  • 7. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy.
    Haeberli G, Brönnimann M, Hunziker T, Müller U.
    Clin Exp Allergy; 2003 Sep 17; 33(9):1216-20. PubMed ID: 12956741
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum tryptase level is a better predictor of systemic side effects than prostaglandin D2 metabolites during venom immunotherapy in children.
    Cichocka-Jarosz E, Sanak M, Szczeklik A, Brzyski P, Gielicz A, Pietrzyk JJ.
    J Investig Allergol Clin Immunol; 2011 Sep 17; 21(4):260-9. PubMed ID: 21721371
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical effectiveness of hymenoptera venom immunotherapy: a prospective observational multicenter study of the European academy of allergology and clinical immunology interest group on insect venom hypersensitivity.
    Ruëff F, Przybilla B, Biló MB, Müller U, Scheipl F, Seitz MJ, Aberer W, Bodzenta-Lukaszyk A, Bonifazi F, Campi P, Darsow U, Haeberli G, Hawranek T, Küchenhoff H, Lang R, Quercia O, Reider N, Schmid-Grendelmeier P, Severino M, Sturm GJ, Treudler R, Wüthrich B.
    PLoS One; 2013 Sep 17; 8(5):e63233. PubMed ID: 23700415
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings.
    Ewan PW, Deighton J, Wilson AB, Lachmann PJ.
    Clin Exp Allergy; 1993 Aug 17; 23(8):647-60. PubMed ID: 8221268
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase.
    Ruëff F, Przybilla B, Biló MB, Müller U, Scheipl F, Aberer W, Birnbaum J, Bodzenta-Lukaszyk A, Bonifazi F, Bucher C, Campi P, Darsow U, Egger C, Haeberli G, Hawranek T, Kucharewicz I, Küchenhoff H, Lang R, Quercia O, Reider N, Severino M, Sticherling M, Sturm GJ, Wüthrich B, European Academy of Allergy and Clinical Immunology Interest Group.
    J Allergy Clin Immunol; 2010 Jul 17; 126(1):105-11.e5. PubMed ID: 20542320
    [Abstract] [Full Text] [Related]

  • 20. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G, Sin BA, Misirligil Z.
    J Investig Allergol Clin Immunol; 2006 Jul 17; 16(4):232-8. PubMed ID: 16889280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.